Related Experiment Videos
Circulating immune complexes and symptoms in Hodgkin's disease
Lancet (London, England)
|February 28, 1976
Insights
Elevated levels of the third component of complement (C3) indicate immune complexes in untreated Hodgkin
Area of Science:
- Immunology
- Oncology
- Clinical Chemistry
Background:
- Hodgkin's disease (H.D.) is a lymphoma with complex immunological aspects.
- The role of immune complexes in H.D. pathogenesis and prognosis requires further elucidation.
Purpose of the Study:
- To investigate the presence and significance of immune complexes in untreated Hodgkin's disease.
- To correlate C3 levels with clinical symptoms and disease severity in H.D. patients.
Main Methods:
- Analysis of macromolecular plasma fractions from patients with untreated H.D.
- Quantification of the third component of complement (C3).
- Correlation of C3 levels with clinical symptoms (night sweats, fever) and prognosis.
Main Results:
- Significantly increased quantities of C3 were detected in the plasma of H.D. patients.
- Elevated C3 levels suggest the presence of circulating immune complexes.
- C3 levels showed a strong correlation with night sweats and fever, indicators of poor prognosis.
Conclusions:
- Circulating immune complexes, indicated by elevated C3, are present in untreated Hodgkin's disease.
- Detection of these complexes may serve as a biomarker for assessing H.D. severity.
- Further research into immune complex detection could aid in patient management and prognosis prediction.
Abstract:
Increased quantities of the third component of complement (C3) were found in the macromolecular fractions of plasma from patients with untreated Hodgkin's disease (H.D.) These changes provide indirect evidence that immune complexes are present in the plasma of patients with this disease; their presence is closely correlated with the symptoms of night sweats and fever which are associated with a poor prognosis. It is suggested that the detection of circulating complexes may help in assessing the severity of H.D.